^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Tris-CAR-T cell therapy

    i
    Other names: Tris-CAR-T cell therapy, Inverse correlated dual-target, truncated IL7Ra modified CAR -expressing autologous T-lymphocytes, P134 Cell Injection, P134
    Associations
    News
    Trials
    Company:
    Beijing Tiantan Hospital, Tasly
    Drug class:
    CD133-targeted CAR-T immunotherapy, CD44-targeted CAR-T immunotherapy
    Related drugs:
    Associations
    News
    Trials